TELL ME MORE

ABOUT THIS CLINICAL TRIAL for COVID-19 Antibody Therapy

This is an Open Label or Placebo Controlled Safety and Efficacy Study of an Investigational Medicine for COVID-19 in Adults.

 

Clinical Trial for Migraine in Children

Clinical Trial of an Antibody Cocktail for COVID-19

Study Location(s): Owensboro Kentucky, Evansville Indiana

Qualmedica Research is currently enrolling two clinical trials focused on a new antibody therapy developed by Eli Lilly.  The BLAZE 1 study is for pediatric patients age 0 – 17 with underlying risk factors.  The BLAZE 4 study is for patients 12 years and older with underlying risk factors.  You may qualify if you have recenltly tested positive for COVID-19.  If you are exhibiting symptoms of COVID-19, Qualmedica Research may administer a free rapid antigen test to see if you qualify for one of these studies.

There is no cost to participate.  Volunteers receive free investigational medicine and follow-up care.  No insurance needed.  Time and travel reimbursement up to $3000 may be available.

Pin It on Pinterest